Elizabeth Swanson
Pediatric Dermatology · Meridian, IDNPI 1174596951
Payments from drug & device makers
Across 2,605 payments — averaging $1334.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$648K
- Sanofi$619K
- Arcutis Biotherapeutics, Inc.$383K
- Lilly USA, LLC$359K
- Eli Lilly$312K
- Johnson & Johnson$190K
- plus $966K from 34 others
Across 5 payments — averaging $3410.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$10K
- Eli Lilly$6K
- Sanofi$1K
What the payments were for
- Consulting fees$275,70310%
- Speaking & faculty fees$2,143,07878%
- Travel & lodging$301,99011%
- Food & beverage$33,2941%
- Education$2160%
- Gifts$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric dermatology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $117 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.